JP4700193B2 - 脂肪の腸吸収を増加させるための方法および組成物 - Google Patents

脂肪の腸吸収を増加させるための方法および組成物 Download PDF

Info

Publication number
JP4700193B2
JP4700193B2 JP2000568497A JP2000568497A JP4700193B2 JP 4700193 B2 JP4700193 B2 JP 4700193B2 JP 2000568497 A JP2000568497 A JP 2000568497A JP 2000568497 A JP2000568497 A JP 2000568497A JP 4700193 B2 JP4700193 B2 JP 4700193B2
Authority
JP
Japan
Prior art keywords
fatty acid
lysophosphatidylcholine
monoglyceride
agent
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000568497A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002524417A (ja
JP2002524417A5 (https=
Inventor
イエスエアー，デビッド・ダブリュー
Original Assignee
バイオモレキュラー・プロダクツ・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオモレキュラー・プロダクツ・インコーポレーテッド filed Critical バイオモレキュラー・プロダクツ・インコーポレーテッド
Publication of JP2002524417A publication Critical patent/JP2002524417A/ja
Publication of JP2002524417A5 publication Critical patent/JP2002524417A5/ja
Application granted granted Critical
Publication of JP4700193B2 publication Critical patent/JP4700193B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2000568497A 1998-09-08 1999-09-07 脂肪の腸吸収を増加させるための方法および組成物 Expired - Fee Related JP4700193B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
US60/099,430 1998-09-08
PCT/US1999/020427 WO2000013689A1 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Publications (3)

Publication Number Publication Date
JP2002524417A JP2002524417A (ja) 2002-08-06
JP2002524417A5 JP2002524417A5 (https=) 2006-11-02
JP4700193B2 true JP4700193B2 (ja) 2011-06-15

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000568497A Expired - Fee Related JP4700193B2 (ja) 1998-09-08 1999-09-07 脂肪の腸吸収を増加させるための方法および組成物

Country Status (13)

Country Link
US (1) US6426069B1 (https=)
EP (1) EP1119360B1 (https=)
JP (1) JP4700193B2 (https=)
CN (1) CN1321089A (https=)
AT (1) ATE347371T1 (https=)
AU (1) AU771901B2 (https=)
CA (1) CA2343116C (https=)
DE (1) DE69934325T2 (https=)
IL (2) IL141801A0 (https=)
NO (1) NO20011173L (https=)
NZ (1) NZ510536A (https=)
WO (1) WO2000013689A1 (https=)
ZA (1) ZA200102268B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161178A0 (en) * 2001-10-11 2004-08-31 Biomolecular Products Inc MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
DE60238663D1 (de) 2002-04-05 2011-02-03 Nestle Sa Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
JP2006518384A (ja) * 2003-01-31 2006-08-10 チルドレンズ・ホスピタル・ロス・アンジエルス 改善されたバイオアベイラビリティを有するフェンレチニドの経口組成物、およびその使用方法
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
US10463229B2 (en) * 2010-10-22 2019-11-05 Fukuoka University Endoscopic observation method and composition for improving diagnostic performance involving applying useful white opaque substance to diagnosis of gastric epithelial tumors (adenoma or gastric cancer)
CA2817957C (en) * 2010-11-15 2016-05-10 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
AU2019342421B2 (en) * 2018-09-21 2024-09-05 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)
WO2025148196A1 (zh) * 2024-01-12 2025-07-17 小藻科技(安吉)有限公司 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
ES2071332T3 (es) 1990-08-13 1995-06-16 David W Yesair Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
JPH11506780A (ja) * 1995-06-06 1999-06-15 バイオモレキュラー プロダクツ，インク． 薬またはカロリー送達用の混合脂質−重炭酸塩コロイド粒子
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
WO1998010776A1 (en) * 1996-09-11 1998-03-19 Shanahan Prendergast Elizabeth Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

Also Published As

Publication number Publication date
DE69934325D1 (de) 2007-01-18
US6426069B1 (en) 2002-07-30
WO2000013689A1 (en) 2000-03-16
ZA200102268B (en) 2001-09-19
EP1119360A4 (en) 2003-06-04
CN1321089A (zh) 2001-11-07
IL141801A (en) 2009-02-11
CA2343116C (en) 2008-11-18
NO20011173D0 (no) 2001-03-07
ATE347371T1 (de) 2006-12-15
JP2002524417A (ja) 2002-08-06
NZ510536A (en) 2003-07-25
NO20011173L (no) 2001-05-08
EP1119360B1 (en) 2006-12-06
CA2343116A1 (en) 2000-03-16
EP1119360A1 (en) 2001-08-01
AU771901B2 (en) 2004-04-08
AU5705299A (en) 2000-03-27
IL141801A0 (en) 2002-03-10
DE69934325T2 (de) 2007-07-05

Similar Documents

Publication Publication Date Title
CN100418519C (zh) 用于增强认知能力的含有花生四烯酸或其与二十二碳六烯酸的组合的组合物
WO2008149177A2 (en) Marine lipid compositions and uses thereof
JP4700193B2 (ja) 脂肪の腸吸収を増加させるための方法および組成物
EP3361885B1 (en) Infant formula with special lipid architecture for promoting healthy growth
SK112399A3 (en) Methods and compositions for reducing the incidence of necrotizing enterocolitis
CN101336913A (zh) 具有预防或改善脑功能降低引起的症状或疾病的作用的组合物
JP2004531568A (ja) 補酵素ｑおよびエイコサペンタエン酸（ｅｐａ）
JPH08193028A (ja) ヘリコバクターの阻害
US20050154064A1 (en) Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
EP2498628A1 (en) Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
JPH08500332A (ja) 炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用
JP3467794B2 (ja) 学習能向上剤
JP5674652B2 (ja) 神経障害の処置のためのアセトアセテートのモノグリセリドおよび誘導体
US20080058286A1 (en) Novel applications of omega-3 rich phospholipids
WO2000009138A1 (en) Nutritional compositions for preventing or treating hyperlipoproteinemia
US7842679B2 (en) Phospholipid derivatives of DHA and methods for treating respiratory failure using the same
CN118416114A (zh) 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用
Tamargo et al. Pharmacokinetics and safety profile of omega-3 polyunsaturated fatty acids
JP2022533316A (ja) 食品用ブチレート
JPS62111926A (ja) コリン作働性神経系活性化剤
JPWO2000009138A1 (ja) 高リポタンパク血症予防用または治療用の栄養組成物
Staggers Lipid digestion and absorption in the suckling rat.
EP1747014A2 (en) Modulation of lysophosphatidylcholine and treatment of diet-induced conditions
O’Shea et al. 11 Clinical Benefits of a Structured Lipid
British Nutrition Foundation Absorption of Unsaturated Fatty Acids

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060907

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091210

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100309

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100316

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100326

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100402

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100610

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100611

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100706

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101006

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101014

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20110106

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110204

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110304

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees